- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kintor Pharmaceutical Ltd (9939)
Kintor Pharmaceutical Ltd stock price live, this page displays HK 9939 stock exchange data. View the 9939 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kintor Pharmaceutical Ltd real time stock price chart below.
What Is the Kintor Pharmaceutical Ltd Stock Price Today?
The Kintor Pharmaceutical Ltd stock price today is 1.94.
What Is the Stock Symbol for Kintor Pharmaceutical Ltd?
The stock symbol for Kintor Pharmaceutical Ltd is "9939."
What Stock Exchange Does Kintor Pharmaceutical Ltd Trade On?
Kintor Pharmaceutical Ltd is listed and trades on the Hong Kong stock exchange.
Is Kintor Pharmaceutical Ltd a Good Stock to Buy?
Determining whether Kintor Pharmaceutical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9939 quote. (ISIN: KYG5273B1077)
What Is the Kintor Pharmaceutical Ltd Stock Price Today?
The Kintor Pharmaceutical Ltd stock price today is 1.94.
What Is the Stock Symbol for Kintor Pharmaceutical Ltd?
The stock symbol for Kintor Pharmaceutical Ltd is "9939."
What Stock Exchange Does Kintor Pharmaceutical Ltd Trade On?
Kintor Pharmaceutical Ltd is listed and trades on the Hong Kong stock exchange.
Is Kintor Pharmaceutical Ltd a Good Stock to Buy?
Determining whether Kintor Pharmaceutical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9939 quote. (ISIN: KYG5273B1077)
1.94
+0.02(+1.04%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.89
1.98
52 wk Range
1.60
4.70
9939 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.891.98
52 wk Range
1.604.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
9939 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Earnings
Latest Release
Aug 19, 2026
EPS / Forecast
-0.15 / --
Revenue / Forecast
52.04M / --
Compare 9939 to Peers and Sector
Metrics to compare | 9939 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship9939PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.2x | −10.8x | −0.4x | |
PEG Ratio | 1.06 | 0.06 | 0.00 | |
Price/Book | 7.5x | 4.9x | 2.6x | |
Price / LTM Sales | 10.4x | 13.2x | 3.1x | |
Upside (Analyst Target) | - | 40.3% | 55.6% | |
Fair Value Upside | Unlock | −1.1% | 7.8% | Unlock |
Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology. Its product candidates include KX-826, a potential topical drug for the treatment of androgenic alopecia (AGA) and acne vulgaris, which is in phase III clinical trial; and GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris that is in phase II clinical trial. The company is also developing ALK-1 Antibody (GT90001), an anti-angiogenesis inhibitor and targets a new biological target activin receptor-like kinase-1 globally to treat metastatic hepatocellular carcinoma, a common type of liver cancer, and a variety of solid tumours that is in phase I and II clinical trial; GT1708F (Hedgehog/SMO Inhibitor), an inhibitor of the hedgehog signal transduction pathway to treat idiopathic pulmonary fibrosis, and blood cancer that is in phase I clinical trial; and GT0486, an inhibitor of the PI3K/mTOR signalling pathway and a second generation mTOR inhibitor for the treatment of metastatic solid tumours, such as breast cancer, prostate cancer, and hepatocellular carcinoma (HCC) that is in phase I clinical trial. Kintor Pharmaceutical Limited was founded in 2009 and is headquartered in Suzhou, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Kintor Pharma (9939) Stock Price Today?
The Kintor Pharma stock price today is 1.94 HKD.
What Stock Exchange Does Kintor Pharma Trade On?
Kintor Pharma is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Kintor Pharma?
The stock symbol for Kintor Pharma is "9939."
What Is the Kintor Pharma Market Cap?
As of today, Kintor Pharma market cap is 957.99M HKD.
What Is Kintor Pharma's Earnings Per Share (TTM)?
The Kintor Pharma EPS (TTM) is -0.40.
From a Technical Analysis Perspective, Is 9939 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Kintor Pharma Stock Split?
Kintor Pharma has split 0 times.
How Many Employees Does Kintor Pharma Have?
Kintor Pharma has 122 employees.
What is the current trading status of Kintor Pharma (9939)?
As of Sep 24, 2026, Kintor Pharma (9939) is trading at a price of 1.94 HKD, with a previous close of 1.94 HKD. The stock has fluctuated within a day range of 1.89 HKD to 1.98 HKD, while its 52-week range spans from 1.60 HKD to 4.70 HKD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.